These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32507383)

  • 1. Thrombin Generation in a patient with Triple Positive Antiphospholipid Syndrome Treated with Three Different Anticoagulants.
    Bergstrom CP; Zia A; Sarode R; Nagalla S
    Transfus Apher Sci; 2020 Oct; 59(5):102815. PubMed ID: 32507383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.
    Cohen H; Doré CJ; Clawson S; Hunt BJ; Isenberg D; Khamashta M; Muirhead N;
    Lupus; 2015 Sep; 24(10):1087-94. PubMed ID: 25940537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature.
    Dufrost V; Risse J; Zuily S; Wahl D
    Curr Rheumatol Rep; 2016 Dec; 18(12):74. PubMed ID: 27812956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of direct oral anticoagulants in antiphospholipid syndrome.
    Cohen H; Efthymiou M; Isenberg DA
    J Thromb Haemost; 2018 Jun; 16(6):1028-1039. PubMed ID: 29624847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis.
    Dufrost V; Risse J; Reshetnyak T; Satybaldyeva M; Du Y; Yan XX; Salta S; Gerotziafas G; Jing ZC; Elalamy I; Wahl D; Zuily S
    Autoimmun Rev; 2018 Oct; 17(10):1011-1021. PubMed ID: 30103045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials.
    Dufrost V; Wahl D; Zuily S
    Autoimmun Rev; 2021 Jan; 20(1):102711. PubMed ID: 33197580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic events in patients with antiphospholipid syndrome treated with rivaroxaban: a series of eight cases.
    Signorelli F; Nogueira F; Domingues V; Mariz HA; Levy RA
    Clin Rheumatol; 2016 Mar; 35(3):801-5. PubMed ID: 26219490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of the antiphospholipid syndrome with direct oral anticoagulantsPosition statement of German societies.
    Bauersachs R; Langer F; Kalka C; Konstantinides S; Klamroth R; Oldenburg J; Schellong S; Scholz U; Stücker M; Lindhoff-Last E
    Vasa; 2019 Nov; 48(6):483-486. PubMed ID: 31621546
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.
    Malec K; Góralczyk T; Undas A
    Thromb Res; 2017 Apr; 152():93-97. PubMed ID: 27989533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the appropriate anticoagulation strategy for thrombotic antiphospholipid syndrome?
    Arachchillage DRJ; Laffan M
    Br J Haematol; 2020 Apr; 189(2):216-227. PubMed ID: 32108324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct oral anticoagulants: an alternative treatment for thrombotic antiphospholipid syndrome?
    Resseguier AS; Pereira B; Rieu V; Le Guenno G; Grobost V; Ruivard M
    Lupus; 2017 Oct; 26(12):1297-1303. PubMed ID: 28355988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct oral anticoagulants versus warfarin in patients with single or double antibody-positive antiphospholipid syndrome.
    Williams B; Saseen JJ; Trujillo T; Palkimas S
    J Thromb Thrombolysis; 2022 Jul; 54(1):67-73. PubMed ID: 34817786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid syndrome: a clinical perspective.
    Zuo Y; Shi H; Li C; Knight JS
    Chin Med J (Engl); 2020 Apr; 133(8):929-940. PubMed ID: 32265421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct oral anticoagulants versus vitamin K antagonists in antiphospholipid syndrome: A meta-analysis.
    Cerdà P; Becattini C; Iriarte A; Hernández JC; Corbella X; Riera-Mestre A
    Eur J Intern Med; 2020 Sep; 79():43-50. PubMed ID: 32482595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent Thrombosis With Direct Oral Anticoagulants in Antiphospholipid Syndrome: A Systematic Literature Review and Meta-analysis.
    Sanchez-Redondo J; Espinosa G; Varillas Delgado D; Cervera R
    Clin Ther; 2019 Sep; 41(9):1839-1862. PubMed ID: 31405527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct oral anticoagulants in antiphospholipid syndrome: a real life case series.
    Betancur JF; Bonilla-Abadía F; Hormaza AA; Jaramillo FJ; Cañas CA; Tobón GJ
    Lupus; 2016 May; 25(6):658-62. PubMed ID: 26743321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody profiles comprising anti phosphatidylserine/prothrombin differently affect thrombin generation and protein C resistance in antiphospholipid antibody carriers.
    Cheng C; Pontara E; Tonello M; Cattini MG; Bison E; Denas G; Pengo V
    Clin Chim Acta; 2020 Nov; 510():796-801. PubMed ID: 32976830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Insights into the Use of Direct Oral Anticoagulants in Non-high Risk Thrombotic APS Patients: Literature Review and Subgroup Analysis from a Meta-analysis.
    Dufrost V; Darnige L; Reshetnyak T; Vorobyeva M; Jiang X; Yan XX; Gerotziafas G; Jing ZC; Elalamy I; Wahl D; Zuily S
    Curr Rheumatol Rep; 2020 May; 22(7):25. PubMed ID: 32436109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.
    Cohen H; Hunt BJ; Efthymiou M; Arachchillage DR; Mackie IJ; Clawson S; Sylvestre Y; Machin SJ; Bertolaccini ML; Ruiz-Castellano M; Muirhead N; Doré CJ; Khamashta M; Isenberg DA;
    Lancet Haematol; 2016 Sep; 3(9):e426-36. PubMed ID: 27570089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS).
    Balbi GGM; Pacheco MS; Monticielo OA; Funke A; Danowski A; Santiago MB; Staub HL; Rêgo J; de Andrade DCO
    Adv Rheumatol; 2020 May; 60(1):29. PubMed ID: 32460902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.